A critical advance in cancer investigation is occurring with the use of VHH fragments to re-engage damaged p53. This crucial tumor inhibitor protein is frequently inactivated in several types of tumors, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research